Omega Healthcare Investors (OHI) Stock Rating Reaffirmed by Bank of America
Omega Healthcare Investors (NYSE:OHI)‘s stock had its “hold” rating restated by investment analysts at Bank of America in a report issued on Monday.
Several other equities research analysts have also recently commented on the stock. Raymond James raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $38.00 target price for the company in a research report on Friday, November 16th. TheStreet raised shares of Omega Healthcare Investors from a “c” rating to a “b-” rating in a research report on Thursday, November 8th. Stifel Nicolaus set a $34.00 target price on shares of Omega Healthcare Investors and gave the stock a “hold” rating in a research report on Monday, November 5th. MED raised their target price on shares of Omega Healthcare Investors to $34.00 and gave the stock a “neutral” rating in a research report on Monday, November 5th. Finally, Zacks Investment Research raised shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research report on Wednesday, October 31st. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $32.50.
NYSE:OHI opened at $36.48 on Monday. Omega Healthcare Investors has a 12 month low of $24.90 and a 12 month high of $36.54. The company has a debt-to-equity ratio of 1.21, a current ratio of 4.17 and a quick ratio of 4.17. The stock has a market capitalization of $7.08 billion, a PE ratio of 11.05, a P/E/G ratio of 5.95 and a beta of 0.13.
In related news, insider Michael Ritz sold 6,000 shares of Omega Healthcare Investors stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $34.75, for a total transaction of $208,500.00. Following the completion of the transaction, the insider now directly owns 10,076 shares of the company’s stock, valued at approximately $350,141. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.65% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the stock. BerganKDV Wealth Management LLC purchased a new position in Omega Healthcare Investors during the 2nd quarter valued at about $110,000. Stratos Wealth Partners LTD. purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at about $132,000. Meeder Asset Management Inc. lifted its position in Omega Healthcare Investors by 69.3% during the 3rd quarter. Meeder Asset Management Inc. now owns 4,184 shares of the real estate investment trust’s stock valued at $137,000 after acquiring an additional 1,712 shares during the period. Point72 Hong Kong Ltd bought a new stake in Omega Healthcare Investors during the 2nd quarter valued at about $147,000. Finally, Bell Rock Capital LLC bought a new stake in Omega Healthcare Investors during the 3rd quarter valued at about $158,000. 73.10% of the stock is owned by institutional investors.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: What is intrinsic value?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.